Association of CD58 polymorphism and multiple sclerosis in Malaysia: a pilot study

[1]  Dan J Stein,et al.  Global, regional, and national burden of Alzheimer's disease and other dementias, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2019, The Lancet Neurology.

[2]  L. Thygesen,et al.  Incidence of MS has increased markedly over six decades in Denmark particularly with late onset and in women , 2018, Neurology.

[3]  David H. Miller,et al.  Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria , 2017, The Lancet Neurology.

[4]  Eyal Oren,et al.  Global, regional, and national burden of neurological disorders, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016 , 2017, The Lancet. Neurology.

[5]  C. Koebnick,et al.  Breastfeeding, ovulatory years, and risk of multiple sclerosis , 2017, Neurology.

[6]  Zunnan Huang,et al.  Association of EVI5 rs11808092, CD58 rs2300747, and CIITA rs3087456 polymorphisms with multiple sclerosis risk: A meta-analysis , 2016, Meta gene.

[7]  Å. Lernmark,et al.  Identification of Non-HLA Genes Associated with Celiac Disease and Country-Specific Differences in a Large, International Pediatric Cohort , 2016, PloS one.

[8]  A. Traboulsee,et al.  International consensus diagnostic criteria for neuromyelitis optica spectrum disorders , 2015, Neurology.

[9]  F. Karami,et al.  Association of CD58 Polymorphism with Multiple Sclerosis and Response to Interferon ß Therapy in A Subset of Iranian Population , 2015, Cell journal.

[10]  M. Hecker,et al.  CD58 and Multiple Sclerosis: Genetic Association, Gene Expression And Prognostic Value (P6.156) , 2014 .

[11]  H. Shin,et al.  CD58 polymorphisms associated with the risk of neuromyelitis optica in a Korean population , 2014, BMC Neurology.

[12]  R. Kundapur,et al.  Prevalence and patterns of demyelinating central nervous system disorders in urban Mangalore, South India , 2014, Multiple sclerosis.

[13]  S. Muda,et al.  Multiple Sclerosis in Malaysia: Demographics, Clinical Features, and Neuroimaging Characteristics , 2013, Multiple sclerosis international.

[14]  Eun Pyo Hong,et al.  Sample Size and Statistical Power Calculation in Genetic Association Studies , 2012, Genomics & informatics.

[15]  Rock Heyman,et al.  Multiple Sclerosis: Pathogenesis and Treatment , 2011, Current neuropharmacology.

[16]  Shuhua Xu,et al.  Population Genetic Structure of Peninsular Malaysia Malay Sub-Ethnic Groups , 2011, PloS one.

[17]  M. Ban,et al.  Evaluation of the established non-MHC multiple sclerosis loci in an Indian population , 2011, Multiple sclerosis.

[18]  M. Saadatnia,et al.  The role of non-HLA single nucleotide polymorphisms in multiple sclerosis susceptibility , 2010, Journal of Neuroimmunology.

[19]  A. Janssens,et al.  Replication of CD58 and CLEC16A as genome-wide significant risk genes for multiple sclerosis , 2009, Journal of Human Genetics.

[20]  P. D. De Jager,et al.  Multiple sclerosis susceptibility alleles in African Americans , 2009, Genes and Immunity.

[21]  Pablo Moscato,et al.  Genome-wide association study identifies new multiple sclerosis susceptibility loci on chromosomes 12 and 20 , 2009, Nature Genetics.

[22]  T. Olsson,et al.  Differential expression, and genetic association, of CD58 in Swedish multiple sclerosis patients , 2009, Proceedings of the National Academy of Sciences.

[23]  Margaret A. Pericak-Vance,et al.  The role of the CD58 locus in multiple sclerosis , 2009, Proceedings of the National Academy of Sciences.

[24]  Michael R. Johnson,et al.  Genome-wide association analysis of susceptibility and clinical phenotype in multiple sclerosis. , 2009, Human molecular genetics.

[25]  H. Chong,et al.  A review of multiple sclerosis with Asian perspective. , 2008, The Medical journal of Malaysia.

[26]  S. Gabriel,et al.  Risk alleles for multiple sclerosis identified by a genomewide study. , 2007, The New England journal of medicine.

[27]  M. Rewers,et al.  Association of non-HLA genes with type 1 diabetes autoimmunity. , 2005, Diabetes.

[28]  M. Daly,et al.  A high-density screen for linkage in multiple sclerosis. , 2005, American journal of human genetics.

[29]  Clare Baecher-Allan,et al.  Loss of Functional Suppression by CD4+CD25+ Regulatory T Cells in Patients with Multiple Sclerosis , 2004, The Journal of experimental medicine.

[30]  C. Hughes,et al.  Endothelial Cell Costimulation of T Cell Activation Through CD58-CD2 Interactions Involves Lipid Raft Aggregation1 , 2001, The Journal of Immunology.

[31]  S. Davis,et al.  The structure and ligand interactions of CD2: implications for T-cell function. , 1996, Immunology today.

[32]  C. Tan,et al.  Multiple sclerosis in Malaysia. , 1988, Archives of neurology.

[33]  N. Prayoonwiwat,et al.  A retrospective study of multiple sclerosis in Thailand , 2010 .

[34]  Ht Chong.  Multiple sclerosis in South East Asia and diagnostic criteria for Asians , 2008 .

[35]  Hilde van der Togt,et al.  Publisher's Note , 2003, J. Netw. Comput. Appl..